The original study, published earlier in the same journal, compared a home sleep apnea test built around photoplethysmography, a small optical sensor that tracks blood volume pulses at the periphery, against the gold standard of in-laboratory polysomnography in children between two and six years of age. That age range matters enormously. Preschool children have shorter sleep cycles, faster breathing rates, and narrower upper airways than adults, which makes obstructive sleep apnea in this group both harder to detect and more consequential when missed. Untreated pediatric sleep apnea is associated with behavioral problems, impaired growth, cardiovascular strain, and disrupted cognitive development, so the stakes of getting the diagnostic pathway right are unusually high.

Polysomnography, the current reference standard, requires a child to sleep overnight in a sleep laboratory wired to an array of electrodes and sensors that record brain activity, eye movements, muscle tone, airflow, respiratory effort, and blood oxygenation. For a toddler, this is an alien and often distressing environment. Sleep laboratories that serve children routinely report first-night effects, in which the unfamiliar setting fragments sleep so severely that the recorded night fails to represent the child’s typical breathing at home. Access is another bottleneck: pediatric sleep laboratories are concentrated in academic medical centers, and waiting lists of many months are common. A reliable test that a child can wear in their own bed would, in principle, collapse both barriers at once.

Photoplethysmography is the technology wagering that it can deliver that reliability. The sensor emits light into the skin and measures how much is absorbed by pulsating blood, producing a waveform that encodes each heartbeat and, crucially, the modulations imposed on blood flow by breathing. When the upper airway collapses during an obstructive event, intrathoracic pressure swings and sympathetic nervous system responses leave characteristic signatures in the pulse waveform, including cyclic amplitude variation and transient vasoconstriction. Algorithms can extract an apnea-hypopnea index from these signals alone, dispensing with the airflow cannulas and chest bands that young children tend to pull off. The Mayo study put this proposition to a direct test, comparing the home device’s index against the one derived from simultaneous or paired polysomnography.

The critique that prompted the reply, authored by Devi and published in the journal’s correspondence section, raised methodological considerations about how the diagnostic accuracy of such home tests should be assessed in children. Questions of this kind are not academic hair-splitting. Diagnostic accuracy studies live or die on the details of their reference standard, their patient spectrum, and the statistical treatment of paired measurements. If a validation study enrolls children whose disease prevalence or severity differs from the population in which the device will actually be used, the reported sensitivity and specificity will not transfer. If the reference test itself is imperfect, as polysomnography is even under ideal conditions, then apparent device error may partly reflect error in the comparator rather than in the new test.

These concerns sharpen considerably in pediatric populations. Scoring rules for pediatric polysomnography differ from adult rules in ways that materially change the apnea-hypopnea index: respiratory events in children can be shorter, the threshold for hypopnea is defined differently, and the normal range of the index in healthy children is far lower than in adults, where an index of five events per hour is a common cutoff. A device validated against adult scoring conventions can look deceptively accurate or deceptively inaccurate when transplanted into a preschool cohort. Any methodological debate about pediatric home testing therefore has to grapple with which scoring standard was applied, how respiratory events were adjudicated, and whether the analysis accounted for the inherent variability of sleep breathing from one night to the next.

In their reply, the Mayo authors address the critique directly and defend the choices made in their validation study. The correspondence is brief by design, but its publication signals that the team regards the methodological questions as answerable within the framework of their original work rather than as fatal flaws. The authors report no competing interests and no external funding for the reply, and all four contributors state that they participated in drafting or critically revising the letter. The exchange follows the classic structure of scientific self-correction: a validation study, a public challenge to its methods, and a documented response that lets readers judge the strength of the evidence for themselves.

What makes this dispute worth wider attention is the clinical future it is arguing about. Home sleep apnea testing has already transformed adult sleep medicine, shifting routine diagnosis out of the laboratory and into the bedroom for large groups of patients. Children have been deliberately excluded from that shift, largely because the evidence base in pediatric populations has been thin and the consequences of a missed diagnosis are heavier. If photoplethysmography-based devices can be validated rigorously in preschool children, the pathway to care could shorten dramatically: a pediatrician could send a family home with a small sensor, obtain a night of breathing data in the child’s natural sleep environment, and reserve laboratory polysomnography for complex or ambiguous cases. That triage model would ease pressure on scarce pediatric sleep laboratories and reduce the number of children whose apnea is discovered only after years of snoring, restless sleep, and daytime behavioral problems.

The counterargument, embodied in the critique, is that enthusiasm should not outrun measurement rigor. A home test that performs well in a selected research cohort may falter in the broader clinic, where children with craniofacial anomalies, obesity, neuromuscular disease, or severe developmental differences present breathing patterns that the algorithms were never trained to interpret. Accuracy metrics such as sensitivity, specificity, and the area under the receiver operating characteristic curve are population-bound quantities, and the correspondence debate is ultimately about how carefully those boundaries are drawn and disclosed. The Mayo team’s willingness to engage the critique in print is itself part of the validation process, because a device destined for children’s bedrooms should be expected to survive exactly this kind of adversarial scrutiny before it is trusted to rule a disorder in or out.

For now, the practical takeaway is that the evidence for home sleep apnea testing in young children is advancing, but under active negotiation. The original validation study, the methodological critique, and the authors’ reply together form a public record that clinicians, guideline committees, and device regulators can weigh as they decide whether and how to extend home testing to the youngest patients. The correspondence was accepted in late September 2026 and published on 12 October 2026, and the underlying study remains available with its full data trail for independent assessment. Whether photoplethysmography can carry the diagnostic load in preschoolers is no longer a speculative question; it is a live research program with named proponents, named critics, and a defined evidentiary standard to meet. The children who snore through the night, and the parents lying awake listening, have a direct stake in how this argument is settled.

Subject of Research: Diagnostic accuracy of photoplethysmography-based home sleep apnea testing compared with polysomnography in young children

Article Title: Reply to “Methodological considerations in assessing diagnostic accuracy of home sleep apnea tests in children”

Article References: Murray, A. M., Morgenthaler, T. I., LeMahieu, A., & Baughn, J. M. (2026). Reply to “Methodological considerations in assessing diagnostic accuracy of home sleep apnea tests in children”. Journal of Clinical Sleep Medicine, 22(1), Article 193. https://doi.org/10.1007/s44470-026-00208-2

Image Credits: AI Generated

DOI: 10.1007/s44470-026-00208-2

Keywords: home sleep apnea test, photoplethysmography, pediatric sleep medicine, obstructive sleep apnea, polysomnography, diagnostic accuracy, children, Mayo Clinic, apnea-hypopnea index, sleep disorders, Journal of Clinical Sleep Medicine, validation study

The study, led by Dr. Ann M. Murray and Dr. Julie M. Baughn along with colleagues at the Mayo Clinic Center for Sleep Medicine, set out to answer a deceptively simple question. Could a photoplethysmography-based home sleep apnea test, worn as a ring, reliably identify obstructive sleep apnea in young children? Photoplethysmography, or PPG, is an old technology finding new life in consumer wearables. It works by shining light into the skin, usually at the fingertip, and measuring how much light is reflected back. Because blood absorbs light differently depending on how much oxygen it carries and how much of it is pulsing through the vessels, a PPG sensor can track pulse rate, blood oxygen saturation, and subtle changes in the pulse waveform. Software algorithms can then infer breathing disturbances from these signals, since each apnea or hypopnea event leaves a characteristic fingerprint in the pulse and oxygen data.

In adults, this approach has proven accurate enough that home testing is now standard practice for many patients with suspected obstructive sleep apnea. Young children, however, are a different physiological and behavioral challenge. Their breathing patterns are faster, their apnea events are often shorter and more subtle, and their small fingers and restless sleep make sensor placement difficult. The American Academy of Sleep Medicine has issued a position paper emphasizing that home sleep apnea tests in children require rigorous validation before widespread adoption, and previous studies have mostly focused on adolescents rather than preschoolers, the age group in which obstructive sleep apnea peaks due to enlarged tonsils and adenoids.

To test the device under the most favorable possible conditions, the researchers enrolled fifty children aged two to six who had already been referred for polysomnography because of suspected obstructive sleep apnea. Rather than sending the device home, the team asked each child to wear the ring-shaped SleepImage PPG sensor concurrently during their standard in-laboratory sleep study. This design is important: it means the new technology was evaluated side by side with the full polysomnographic apparatus, attended by trained technologists, with no risk of the setup errors or lost nights that plague true home testing. If the device struggled even in this ideal scenario, its performance in an unattended home environment would likely be no better.

The results revealed problems at two distinct levels: feasibility and accuracy. Of the fifty children enrolled, thirty-nine completed testing, and even among these the device did not always deliver usable data. Device-related issues such as sensor detachment, intolerance by the child, and user setup errors precluded successful data collection in eleven percent of studies. An additional twenty-five percent of the recordings captured less than two hours of total sleep time as measured by the PPG device, a duration generally considered too short to characterize a child’s sleep-disordered breathing reliably. In other words, in more than a third of cases the device either failed outright or produced too little data to be clinically meaningful, and this occurred under supervised laboratory conditions rather than in a child’s bedroom.

The technical shortfall showed up starkly in the comparison of sleep duration measurements. Using the automated SleepImage scoring software, the mean difference in total sleep time between the PPG device and full polysomnography was minus 220 minutes, a gap of nearly four hours, with a 95 percent confidence interval of minus 278 to minus 62 minutes and a p value below 0.001. This enormous discrepancy reflects the fact that the PPG-based algorithm could not distinguish sleep from wakefulness in young children the way electroencephalography-based polysomnography can. When the researchers created a limited polysomnography dataset, trimming the laboratory recording to include only the periods when PPG data were available, the mean difference in sleep time shrank to just minus 11 minutes, which was not statistically significant. That comparison confirmed the device was capturing data during the same windows of time; it simply could not tell how much of that time the child was actually asleep.

Diagnostic accuracy proved equally troubling. Using automated scoring, the device showed a sensitivity of 94.1 percent for diagnosing obstructive sleep apnea, meaning it correctly flagged most children who truly had the condition. But the specificity was only 22.7 percent, indicating the device frequently produced positive results in children who did not have obstructive sleep apnea on polysomnography. The positive predictive value was 0.48, meaning that fewer than half of the children flagged by the device actually had the diagnosis confirmed by the gold standard, while the negative predictive value of 0.83 was somewhat stronger. The obstructive apnea-hypopnea index, the key severity metric counting breathing pauses and reductions per hour of sleep, was significantly higher when measured by the PPG device than by either full or limited polysomnography, with p values below 0.001. The device also detected no central apnea events at all, a notable omission because central sleep apnea, in which the brain temporarily stops sending breathing signals, is clinically relevant in young children and cannot be assessed by pulse-based inference alone.

There was one genuine bright spot in the findings. Caregivers reported good ease of use and tolerance of the ring-shaped device, suggesting that the fundamental form factor is acceptable even to toddlers and preschoolers who might resist more cumbersome equipment. This matters because the barriers to pediatric sleep diagnosis are not purely technical; they are also human. Polysomnography requires an overnight stay in a sleep laboratory with dozens of electrodes attached to the scalp, chest, abdomen, and face, an experience that can be distressing for young children and demanding for families. Previous work by some of the same Mayo Clinic investigators has focused on improving the emotional experience of pediatric sleep studies, including the use of certified child life specialists to ease setup. A comfortable, minimally invasive alternative remains an attractive goal, which is precisely why rigorous validation studies like this one are needed before such devices are trusted.

The stakes of getting pediatric sleep apnea diagnosis right are considerable. Obstructive sleep apnea affects a meaningful share of preschool-aged children, with systematic reviews suggesting a notable prevalence in the general population, and it has been linked to behavioral problems, impaired learning, cardiovascular strain, and metabolic consequences. The standard treatment, adenotonsillectomy, has been shown in randomized trials to improve sleep and related outcomes even in children with mild disease. Yet the decision to proceed with surgery in a young child is not one to make on the basis of an inaccurate test. A device that overcalls the diagnosis could send children to unnecessary surgery, while one that misses severity could delay needed treatment. The authors conclude that this particular PPG-based home sleep apnea test was technically inadequate and diagnostically inaccurate in children two to six years of age, and they emphasize that future research must determine the best technology and the appropriate ages of use before any home sleep apnea test can be recommended for widespread use in children. For now, the message for parents and clinicians is clear: when it comes to diagnosing sleep apnea in preschoolers, the overnight laboratory study remains the standard that home gadgets have yet to meet.

Subject of Research: Validation of a photoplethysmography-based home sleep apnea test against polysomnography for diagnosing obstructive sleep apnea in preschool children

Article Title: A photoplethysmography-based home sleep apnea test compared with polysomnography in children 2 to 6 years of age

Article References: Murray, A. M., Matarese, C. A., Lloyd, R. M., Sorensen, C., LeMahieu, A., Reckward, D., Tullis, R., Bellinger, M., Brown, V., Herold, D. L., Morgenthaler, T. I., & Baughn, J. M. (2026). A photoplethysmography-based home sleep apnea test compared with polysomnography in children 2 to 6 years of age. Journal of Clinical Sleep Medicine, 22(1), Article 140. https://doi.org/10.1007/s44470-026-00156-x

Image Credits: AI Generated

DOI: 10.1007/s44470-026-00156-x

Keywords: pediatric sleep apnea, home sleep apnea test, photoplethysmography, polysomnography, preschool children, obstructive sleep apnea, SleepImage, apnea-hypopnea index, sleep medicine, diagnostic accuracy, Mayo Clinic, wearable sensors

The letter, written by Anmol Devi of Ghulam Muhammad Mahar Medical College in Sukkur, Pakistan, examines a recent study by Murray and colleagues that evaluated a photoplethysmography-based home sleep apnea test, known as PPG-HSAT, against polysomnography in children aged two to six years. Polysomnography, or PSG, remains the gold standard for diagnosing obstructive sleep apnea in children, but it is expensive, resource-intensive, and often uncomfortable for young patients. A reliable home alternative would be transformative, allowing clinicians to screen and diagnose far more children in their own sleep environments. The appeal is obvious, which is precisely why Devi argues that the methodological details behind accuracy claims deserve close scrutiny.

The first concern centers on what happens when the home test simply fails to produce usable data. In the original study, 43 children attempted concurrent testing with both the home device and laboratory polysomnography. Four of them, roughly nine percent, had no interpretable PPG-HSAT data at all. Among the 39 children with some captured data, a further 11, or 28 percent, had less than two hours of recorded sleep. Despite these substantial losses, the study calculated sensitivity, specificity, positive predictive value, and negative predictive value only among the children whose home recordings were successfully captured. The headline figures were striking: a sensitivity of 94.1 percent, meaning the device caught nearly all true cases, but a specificity of just 22.7 percent, meaning it flagged many children as positive who did not have the condition by the reference standard.

Devi’s argument is that these numbers may not mean what they appear to mean. In diagnostic accuracy research, excluding missing or inconclusive index-test results is a well-recognized source of bias. When only technically successful recordings are analyzed, the study population becomes a selected subset, potentially healthier in terms of device tolerance or simply easier to monitor, and therefore less representative of the intended clinical population. A device that fails in a quarter of attempted recordings is not the same device, in clinical terms, as one evaluated only where it worked. The reported sensitivity and specificity may reflect performance among technically successful recordings rather than the overall diagnostic effectiveness of the test as it would be deployed in practice.

The solution Devi proposes draws on established methodological literature. An intention-to-diagnose analysis, analogous in spirit to intention-to-treat analysis in therapeutic trials, would classify technically unsuccessful studies as indeterminate or failed tests rather than discarding them. This approach, supported by a scoping review of methods for handling missing values and inconclusive results in diagnostic studies published in Statistical Methods in Medical Research, yields estimates that better reflect real-world performance. It answers the question clinicians actually face: if I prescribe this home test for a toddler suspected of having sleep apnea, how likely am I to get an accurate answer, or any answer at all? A test with excellent accuracy conditional on success but a high failure rate may be far less useful than its published numbers suggest.

The second methodological concern involves the reference standard itself. Polysomnography is only as unbiased as the people interpreting it, and Devi notes that in the original study, PSG technologists and physicians were not blinded to study participation. Moreover, the PSG interpretation incorporated audiovisual findings, including snoring, mouth breathing, and airway-protective maneuvers. These observations are clinically valuable, but they also carry subjective judgment, and their integration into the diagnostic classification opens the door to what the literature calls diagnostic review bias, which arises when interpreters of the reference standard are aware of the index-test result or the investigational context.

The letter acknowledges that the original authors reported the SleepImage data, the commercial PPG-based system under evaluation, were reviewed independently at a later time. That is an important safeguard for the index test. What remains unclear, Devi writes, is whether the PSG interpretation was fully independent of the investigational testing context. If the sleep technologists scoring the reference standard knew that a child was part of a study evaluating a home apnea test, even subtle expectations could color their reading of borderline respiratory events. This may be particularly consequential in pediatric obstructive sleep apnea, where classification often hinges on borderline cases and where clinical and audiovisual findings, such as a parent’s report of snoring or visible mouth breathing, can influence whether a child crosses the diagnostic threshold.

Diagnostic review bias is not a hypothetical worry. Reviews of diagnostic accuracy methodology, including work published in Radiology Research and Practice on recognizing and addressing sources of bias, have repeatedly shown that unblinded reference-standard interpretation can inflate apparent agreement between tests and distort estimates of sensitivity and specificity. In fields like radiology, where imaging studies are routinely compared against clinical reference standards, blinding procedures are now considered a core quality marker of accuracy research. Sleep medicine, Devi implies, should hold itself to the same standard, especially as commercial home-testing platforms seek regulatory approval and clinical adoption on the basis of validation studies.

Importantly, the letter does not claim that the original study’s findings are invalid. Devi explicitly states that these issues do not invalidate the study, but that they may affect the reported estimates of diagnostic performance. The distinction matters. The Murray study addresses an important clinical question, and the underlying data remain valuable. The concern is about interpretation: how far the reported sensitivity of 94.1 percent and specificity of 22.7 percent can be generalized to the population of children who would actually be offered the test, including those whose recordings fail or fall short of adequate sleep duration.

The broader stakes extend well beyond a single study. Pediatric obstructive sleep apnea affects a meaningful share of preschool children and is associated with behavioral problems, poor growth, cardiovascular strain, and impaired quality of life. Untreated, it can shape a child’s development during critical years. Yet access to polysomnography is limited in many regions, and waiting lists for pediatric sleep laboratories can stretch for months. If home sleep apnea tests can be validated rigorously for young children, the public health payoff could be enormous: earlier diagnosis, earlier treatment with adenotonsillectomy or other interventions, and reduced burden on families. That promise is exactly why methodological rigor in validation studies is not an academic nicety but a prerequisite for safe clinical adoption.

Devi’s recommendations are concrete. Future evaluations of pediatric home sleep apnea tests should account for technically unsuccessful recordings, reporting them transparently and incorporating them into intention-to-diagnose analyses, and should ensure independent, ideally blinded, interpretation of the reference standard. Such measures would provide more robust and clinically meaningful estimates of accuracy, allowing clinicians and regulators to judge these devices on the terms that matter: how they perform in the full population of children who would use them, not just the subset in whom they happen to work. As home testing moves from novelty toward standard of care, the letter serves as a timely reminder that in diagnostic medicine, the fine print of methodology often determines whether a promising technology earns its place at the bedside, or in this case, the child’s own bedroom.

Subject of Research: Methodological biases in validating home sleep apnea tests against polysomnography in preschool children

Article Title: Methodological considerations in assessing diagnostic accuracy of home sleep apnea tests in children

Article References: Devi, A. (2026). Methodological considerations in assessing diagnostic accuracy of home sleep apnea tests in children. Journal of Clinical Sleep Medicine, 22(1), Article 159. https://doi.org/10.1007/s44470-026-00185-6

Image Credits: AI Generated

DOI: 10.1007/s44470-026-00185-6

Keywords: home sleep apnea test, pediatric sleep apnea, polysomnography, photoplethysmography, diagnostic accuracy, intention-to-diagnose analysis, diagnostic review bias, PPG-HSAT, children aged 2 to 6, sleep medicine, reference standard blinding, Journal of Clinical Sleep Medicine